Since February 2015, Dr. Mathew T Thomas serves as the Director of the U.S. FDA India Office. Prior to this posting, Dr. Thomas was the Director of the Division of Enforcement and Post-market Safety (DEPS), in U.S. FDA's Center for Drug Evaluation and Research (CDER), Office of Compliance (OC), Office of Scientific Investigations (OSI). Dr. Thomas started his FDA career as a medical reviewer in CDER's Division of Metabolism and Endocrine Drug Products. He then moved to CDER's Division of Scientific Investigations (now OSI) where he participated in numerous inspections and official administrative actions and later led the Global Outreach and Collaboration Team for CDER. He has also served in the Office of Orphan Product Development in the Office of the Commissioner and in 2009 served as the Chair of FDA's Research In Human Subjects Committee (RIHSC or FDA's Institutional Review Board). In 2013 he took the role of a Branch Chief in the Division of Enforcement and Manufacturing within the Office of Compliance and Enforcement at the Center for Tobacco Products.
Dr. Thomas earned his medical degree from the University of Madras in India. He has completed a Fellowship in Lipid Disorders at the Medical College of Pennsylvania, Philadelphia; and a Fellowship in Clinical Pharmacology and Regulatory Sciences and a Certification in Public Health at the Georgetown University in Washington D.C. In 2015, he completed an Excellence in Government (EIG) fellowship program that is offered by the Partnership for Public Service in Washington D.C.